Alpha-foetoprotein in umbilical cord in relation to severe pre-eclampsia, birth weight and future breast cancer risk
2002

Alpha-fetoprotein in Umbilical Cord and Its Relation to Pre-eclampsia and Breast Cancer Risk

Sample size: 12804 publication Evidence: moderate

Author Information

Author(s): L J Vatten, P R Romundstad, R A Ødegård, S T Nilsen, D Trichopoulos, A Austgulen

Primary Institution: Norwegian University of Science and Technology

Hypothesis

The anti-oestrogenic effect of pre-eclampsia could be mediated through high intrauterine levels of AFP, rather than low levels of oestradiol.

Conclusion

Higher levels of α-foetoprotein in umbilical cord plasma are associated with severe pre-eclampsia, suggesting a potential link to reduced breast cancer risk.

Supporting Evidence

  • Women born after pre-eclamptic pregnancies have a reduced risk of breast cancer.
  • High levels of α-foetoprotein have anti-oestrogenic properties.
  • Severe pre-eclampsia is associated with higher levels of α-foetoprotein in umbilical cord plasma.

Takeaway

This study found that babies born from mothers with severe pre-eclampsia had higher levels of a protein that might help protect against breast cancer later in life.

Methodology

Umbilical cord blood was collected from 12,804 deliveries, comparing cases of severe pre-eclampsia with controls, measuring oestradiol and α-foetoprotein levels.

Limitations

The study may be confounded by differences in gestational age and the observational nature of the data.

Participant Demographics

The study included women who gave birth at Rogaland Central Hospital, with a focus on those with severe pre-eclampsia and matched controls.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1038/sj.bjc.6600125

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication